R&D In Brief
This article was originally published in The Tan Sheet
Executive Summary
Polypill for CVD prevention: Single daily pill containing six components including folic acid, low-dose aspirin would prevent 88% of heart attacks and 80% of strokes, researchers say in the June 28 British Medical Journal. N.J. Wald, et al., University of London, sought to determine the combination of drugs, vitamins and their doses "for use in a single daily pill to achieve a large effect in preventing cardiovascular disease with minimal adverse effects." With combination of three blood pressure-lowering drugs, a statin, .8 mg folic acid and 75 mg aspirin, researchers predict "about one in three people would directly benefit, each on average gaining 11-12 years of life without a heart attack or stroke." Accompanying editorial suggests trials to assess safety, tolerability are needed; researchers have filed UK patent application for Polypill...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning